ClinicalTrials.Veeva

Menu

The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension

R

Regional Hospital Holstebro

Status

Completed

Conditions

Essential Hypertension and Healthy Controls

Treatments

Behavioral: Low Sodium Diet
Behavioral: high sodium diet

Study type

Interventional

Funder types

Other

Identifiers

NCT00345124
med.res.hos.2006.cc.02

Details and patient eligibility

About

The aim of the study is to test the following hypotheses:

  • that the function and/or regulation of AQP2 and/or ENaC in the principal cells is abnormal in essential hypertension.
  • if an abnormal function of the principal cells is present in essential hypertension, this will become more pronounced at high and low sodium intake.

Enrollment

50 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Caucasian men and women
  • Age 18-65 years
  • Arterial hypertension
  • Body mass index between 18.5 and 30 kg/m2

Exclusion criteria

  • Secondary hypertension
  • Isolated systolic hypertension
  • History or clinical signs of AMI, atrial fibrillation, disease of the heart valves, or chronic heart failure.
  • Malignant disease
  • Prior apoplexy
  • alcohol or drug abuse
  • Drug use except antihypertensives and oral contraceptives
  • Abnormal biochemical screening of the blood regarding: red and white blood count, s-creatinine (> 200 micromol/L), b-hemoglobin, p-Sodium, p- potassium, p-albumine, p-bilirubin, p-alanine aminotransferase, p-alkaline phosphatase, p-cholesterol and b-glucose.
  • Abnormal screening of the urine regarding: Blood, albumine and glucose.
  • abnormal electrocardiogram
  • Blood donation within one month of the first examination day
  • Unwillingness to participate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems